Weng, J. (2026) “Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease”, Gastroenterology Research, 19(3), pp. 147–154. doi:10.14740/gr2136.